113 related articles for article (PubMed ID: 31885098)
41. AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.
Takano APC; Senger N; Munhoz CD; Barreto-Chaves MLM
Pflugers Arch; 2018 Mar; 470(3):549-558. PubMed ID: 29178049
[TBL] [Abstract][Full Text] [Related]
42. Postprandial activation of metabolic and inflammatory signalling pathways in human peripheral mononuclear cells.
Ehlers K; Brand T; Bangert A; Hauner H; Laumen H
Br J Nutr; 2014 Jun; 111(12):2167-75. PubMed ID: 24576401
[TBL] [Abstract][Full Text] [Related]
43. HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities.
Benedyk M; Sopalla C; Nacken W; Bode G; Melkonyan H; Banfi B; Kerkhoff C
J Invest Dermatol; 2007 Aug; 127(8):2001-11. PubMed ID: 17429438
[TBL] [Abstract][Full Text] [Related]
44. Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14).
Leukert N; Sorg C; Roth J
Biol Chem; 2005 May; 386(5):429-34. PubMed ID: 15927886
[TBL] [Abstract][Full Text] [Related]
45. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
46. HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells.
Duan L; Wu R; Zhang X; Wang D; You Y; Zhang Y; Zhou L; Chen W
Cell Death Dis; 2018 May; 9(6):629. PubMed ID: 29795379
[TBL] [Abstract][Full Text] [Related]
47. S100A8, which increases with age, induces cellular senescence-like changes in bovine oviduct epithelial cells.
Nakamura Y; Iwata H; Kuwayama T; Shirasuna K
Am J Reprod Immunol; 2019 Sep; 82(3):e13163. PubMed ID: 31237976
[TBL] [Abstract][Full Text] [Related]
48. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.
Leukert N; Vogl T; Strupat K; Reichelt R; Sorg C; Roth J
J Mol Biol; 2006 Jun; 359(4):961-72. PubMed ID: 16690079
[TBL] [Abstract][Full Text] [Related]
49. Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Spijkers-Hagelstein JA; Schneider P; Hulleman E; de Boer J; Williams O; Pieters R; Stam RW
Leukemia; 2012 Jun; 26(6):1255-65. PubMed ID: 22282267
[TBL] [Abstract][Full Text] [Related]
50. Role of inflammatory proteins S100A8 and S100A9 in pathophysiology of recurrent early pregnancy loss.
Nair RR; Khanna A; Singh K
Placenta; 2013 Sep; 34(9):824-7. PubMed ID: 23850136
[TBL] [Abstract][Full Text] [Related]
51. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.
Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH
Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330
[TBL] [Abstract][Full Text] [Related]
52. JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling.
Schwemmers S; Will B; Waller CF; Abdulkarim K; Johansson P; Andreasson B; Pahl HL
Exp Hematol; 2007 Nov; 35(11):1695-703. PubMed ID: 17764814
[TBL] [Abstract][Full Text] [Related]
53. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions.
Okada K; Arai S; Itoh H; Adachi S; Hayashida M; Nakase H; Ikemoto M
J Leukoc Biol; 2016 Nov; 100(5):1093-1104. PubMed ID: 27312849
[TBL] [Abstract][Full Text] [Related]
54. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.
Boyd JH; Kan B; Roberts H; Wang Y; Walley KR
Circ Res; 2008 May; 102(10):1239-46. PubMed ID: 18403730
[TBL] [Abstract][Full Text] [Related]
55. Glaucomatous MYOC mutations activate the IL-1/NF-κB inflammatory stress response and the glaucoma marker SELE in trabecular meshwork cells.
Itakura T; Peters DM; Fini ME
Mol Vis; 2015; 21():1071-84. PubMed ID: 26396484
[TBL] [Abstract][Full Text] [Related]
56. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells.
Yong HY; Moon A
Arch Pharm Res; 2007 Jan; 30(1):75-81. PubMed ID: 17328245
[TBL] [Abstract][Full Text] [Related]
57. Secretion of the Phosphorylated Form of S100A9 from Neutrophils Is Essential for the Proinflammatory Functions of Extracellular S100A8/A9.
Schenten V; Plançon S; Jung N; Hann J; Bueb JL; Bréchard S; Tschirhart EJ; Tolle F
Front Immunol; 2018; 9():447. PubMed ID: 29593718
[TBL] [Abstract][Full Text] [Related]
58. Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
Chang H; Shih LY; Michelson AD; Dunn P; Frelinger AL; Wang PN; Kuo MC; Lin TL; Wu JH; Tang TC
Acta Haematol; 2013; 130(3):181-7. PubMed ID: 23751441
[TBL] [Abstract][Full Text] [Related]
59. Localization of S100A8 and S100A9 expressing neutrophils to spinal cord during peripheral tissue inflammation.
Mitchell K; Yang HY; Tessier PA; Muhly WT; Swaim WD; Szalayova I; Keller JM; Mezey E; Iadarola MJ
Pain; 2008 Jan; 134(1-2):216-31. PubMed ID: 18063312
[TBL] [Abstract][Full Text] [Related]
60. Correlative study between the JAK2V617F mutation and thrombosis in patients with myeloproliferative neoplasm.
Li ZC; Fu HJ; Wang ZM; Yang S; Xu HZ
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
